ANGLE plc (AGL):企業の製品パイプライン分析2018

◆英語タイトル:ANGLE plc (AGL) - Product Pipeline Analysis, 2018 Update
◆商品コード:DATA904C12783
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:37
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD750 ⇒換算¥82,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD1,500 ⇒換算¥165,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥247,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
ANGLE Plc (ANGLE) is a medical diagnostic company that offers cancer diagnostics and foetal health products. The company develops products for use in rare cell diagnostics that enable early, accurate identification of an individual’s condition for the prevention, treatment, and monitoring of disease. Its product Parsortix cell separation system, which captures very rare circulating tumor cells in cancer patient blood. ANGLE’s Parsortix cell separation system uses a microfluidic technology in the form of a one-time use cassette to capture and then harvest circulating tumor cells (CTCs) from blood. The company’s cassette captures CTCs based on their less deformable nature and larger size compared to other blood components. It provides liquid biopsy (blood test) that enables the detection and investigation of mutations in the patient’s cancer for personalized cancer care. The company’s harvested CTCs have a range of applications such as diagnosis, prognosis, mutational analysis and drug selection, drug development, assessment of treatment effectiveness and remission monitoring. It has operations in the US and the UK. ANGLE is headquartered in Guildford, the UK.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company ANGLE plc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
ANGLE plc Company Overview 5
ANGLE plc Company Snapshot 5
ANGLE plc Pipeline Products and Ongoing Clinical Trials Overview 5
ANGLE plc – Pipeline Analysis Overview 8
ANGLE plc – Key Facts 8
ANGLE plc – Major Products and Services 9
ANGLE plc Pipeline Products by Development Stage 10
ANGLE plc Ongoing Clinical Trials by Trial Status 12
ANGLE plc Pipeline Products Overview 14
Parsortix GEN2 14
Parsortix GEN2 Product Overview 14
Parsortix System 15
Parsortix System Product Overview 15
Parsortix-Based Test – Breast Cancer 16
Parsortix-Based Test – Breast Cancer Product Overview 16
Parsortix-Based Test – Colorectal Cancer 17
Parsortix-Based Test – Colorectal Cancer Product Overview 17
Parsortix-Based Test – Head & Neck Cancer 18
Parsortix-Based Test – Head & Neck Cancer Product Overview 18
Parsortix-Based Test – Lung Cancer 19
Parsortix-Based Test – Lung Cancer Product Overview 19
Parsortix-Based Test – Ovarian Cancer Triage 20
Parsortix-Based Test – Ovarian Cancer Triage Product Overview 20
Parsortix-Based Test – Ovarian Cancer Triage Clinical Trial 21
Parsortix-Based Test – Pancreatic Cancer 22
Parsortix-Based Test – Pancreatic Cancer Product Overview 22
Parsortix-Based Test – Prostate Cancer 23
Parsortix-Based Test – Prostate Cancer Product Overview 23
ANGLE plc – Key Competitors 24
ANGLE plc – Key Employees 25
ANGLE plc – Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Recent Developments 27
ANGLE plc, Recent Developments 27
Jun 04, 2018: ANGLE: Encouraging Progress in ANG-002 FDA Clinical Study 27
May 14, 2018: Angle Appoints Leading NHS Prostate Cancer Surgeon As Scientific Advisor 27
May 03, 2018: Angle and Qiagen Present Poster at Leading Cancer Conference Demonstrating Utility of Angle”s Parsortix System in Conjunction With Qiagen”s Adnatest Assay 28
Apr 19, 2018: Angle”s Parsortix System Showcased In Multiple Presentations At Leading Cancer Conference AACR 2018 28
Apr 19, 2018: Breakthrough Research Demonstrates Parsortix Workflow For Culturing Circulating Tumor Cells For In-Vitro Drug Testing 29
Apr 05, 2018: First Patient Enrolled In Clinical Study To Support FDA Clearance Of The Parsortix System 30
Mar 26, 2018: Angle”S Ovarian Cancer Risk Assessment Achieves The Highest Sensitivity And Specificity For Predicting Cancer 30
Feb 06, 2018: ANGLE: Research Grant From Abbott 31
Jan 31, 2018: ANGLE: Interim Results for the six months ended 31 October 2017 32
Jan 16, 2018: ANGLE: Webinar: Using The Parsortixtm System To Identify Drugs That May Arrest Cancer Metastasis 33
Appendix 34
Methodology 34
About GlobalData 37
Contact Us 37
Disclaimer 37

List of Tables
ANGLE plc Pipeline Products and Ongoing Clinical Trials Overview 5
ANGLE plc Pipeline Products by Equipment Type 6
ANGLE plc Pipeline Products by Indication 7
ANGLE plc Ongoing Clinical Trials by Trial Status 7
ANGLE plc, Key Facts 8
ANGLE plc, Major Products and Services 9
ANGLE plc Number of Pipeline Products by Development Stage 10
ANGLE plc Pipeline Products Summary by Development Stage 11
ANGLE plc Ongoing Clinical Trials by Trial Status 12
ANGLE plc Ongoing Clinical Trials Summary 13
Parsortix GEN2 - Product Status 14
Parsortix GEN2 - Product Description 14
Parsortix System - Product Status 15
Parsortix System - Product Description 15
Parsortix-Based Test - Breast Cancer - Product Status 16
Parsortix-Based Test - Breast Cancer - Product Description 16
Parsortix-Based Test - Colorectal Cancer - Product Status 17
Parsortix-Based Test - Colorectal Cancer - Product Description 17
Parsortix-Based Test - Head & Neck Cancer - Product Status 18
Parsortix-Based Test - Head & Neck Cancer - Product Description 18
Parsortix-Based Test - Lung Cancer - Product Status 19
Parsortix-Based Test - Lung Cancer - Product Description 19
Parsortix-Based Test - Ovarian Cancer Triage - Product Status 20
Parsortix-Based Test - Ovarian Cancer Triage - Product Description 20
Parsortix-Based Test - Ovarian Cancer Triage - Evaluation of Multiple Protein and Molecular Biomarkers to Estimate Risk of Cancer in Gynecology Patients Presenting with a Pelvic Mass: ANG-003 EMBER Study 21
Parsortix-Based Test - Pancreatic Cancer - Product Status 22
Parsortix-Based Test - Pancreatic Cancer - Product Description 22
Parsortix-Based Test - Prostate Cancer - Product Status 23
Parsortix-Based Test - Prostate Cancer - Product Description 23
ANGLE Plc, Key Employees 25
ANGLE Plc, Other Locations 26
Glossary 36

List of Figures
ANGLE plc Pipeline Products by Equipment Type 6
ANGLE plc Pipeline Products by Development Stage 10
ANGLE plc Ongoing Clinical Trials by Trial Status 12

★海外企業調査レポート[ANGLE plc (AGL):企業の製品パイプライン分析2018]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • VWR International LLC:医療機器:M&Aディール及び事業提携情報
    Summary VWR International LLC (VWR), a subsidiary of Avantor Performance Materials Inc, is a provider of product and service solutions to laboratory and production companies. The company offers products such as adhesive dispensers, adhesive labels, adhesive slides, agarose and acrylamide, air freshe …
  • Biomnis SELAS:企業のM&A・提携動向(医療機器分野)
    Summary Biomnis SELAS(Biomnis), a subsidiary of Eurofins Scientific SE, is a company that offers medical pathological testing. The company offers laboratory tests in the areas of generics, biochemistry, immunology, cytogenics, oncology-haemotology, analytical chemistry, assisted reproductive technol …
  • Ujaas Energy Ltd. (UJAAS):企業の財務及び戦略的SWOT分析
    Summary Ujaas Energy Ltd. (Ujaas) is a renewable energy company that provides solar energy development services and products. The company offers products such as park products, home products and transformers. Ujaas’s transformers include convertor and special purpose transformers, power transformers …
  • EnerJex Resources, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' EnerJex Resources, Inc. Mergers …
  • Henry Lamotte Group:戦略・SWOT・企業財務分析
    Henry Lamotte Group - Strategy, SWOT and Corporate Finance Report Summary Henry Lamotte Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Mediaset S.p.A. (MS):企業の財務・戦略的SWOT分析
    Mediaset S.p.A. (MS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Titan Machinery Inc.:企業のM&A・提携・投資分析
    Titan Machinery Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Titan Machinery Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Telefonaktiebolaget LM Ericsson (ERIC B):企業の財務・戦略的SWOT分析
    Telefonaktiebolaget LM Ericsson (ERIC B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Western Areas Limited:企業の戦略・SWOT・財務情報
    Western Areas Limited - Strategy, SWOT and Corporate Finance Report Summary Western Areas Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Glacier Bay, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Glacier Bay, Inc. Mergers and A …
  • Spring Energy Norway AS:企業のM&A・提携動向(石油・ガス分野)
    Summary Spring Energy Norway AS (Spring Energy), a subsidiary of Tullow Oil plc is an oil and gas company that offers exploration services. The company’s activities include exploration, production and development activities for crude oil and natural gas properties among others. It concentrates on bu …
  • Vitro Diagnostics, Inc. (VODG)(製薬・医療分野):企業M&A動向
    Summary Vitro Diagnostics, Inc. (Vitro Diagnostics) is a biopharmaceutical company. The company develops and commercializes adult stem cell technology for stem cell research, drug discovery and development, and therapeutic products. Its products include cell culture media, cell lines, and cell measu …
  • DiaSys Diagnostic Systems GmbH:企業のM&A・提携動向(医療機器分野)
    Summary DiaSys Diagnostic Systems GmbH (DiaSys Diagnostic) is a medical device company that develops, manufactures, and markets point of care disgnostic products. The company offers products such as automated analyzers, calibrators or controls, POCT systems and tests, reagents, system kits, and OEM …
  • Navistar International Corporation:企業のM&A・事業提携・投資動向
    Navistar International Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Navistar International Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on m …
  • MTS Systems Corporation (MTSC):企業の財務及び戦略的SWOT分析
    Summary MTS Systems Corporation (MTS) is a supplier of high-performance test systems and position sensors. The company’s product portfolio includes test components such as controllers, environmental simulation, grips, fixtures and accessories, hydraulic power and distribution, softwares for mechanic …
  • Ramelius Resources Limited:企業の戦略・SWOT・財務情報
    Ramelius Resources Limited - Strategy, SWOT and Corporate Finance Report Summary Ramelius Resources Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • ZoomMed Inc. (ZMD):企業の財務及び戦略的SWOT分析
    Summary ZoomMed Inc. (ZoomMed) is a technical service provider that offers web solutions for medical sectors. The company’s product includes ZoomMed Network, ZRx Prescriber, PraxisLab, and EvPsych. It builds and operates a clinical information exchange platform between physicians and specialists, pa …
  • SNGN Romgaz S.A. (SNG):企業のM&A・提携動向(石油・ガス分野)
    Summary SNGN Romgaz S.A. (Romgaz), formerly Societatea Nationala de Gaze Naturale Romgaz SA is an oil and gas company that explores, produces, and supplies natural gas and electricity. The company provides operation of Iernut thermoelectric power station, and offers electric power supply. Its explor …
  • Amec Foster Wheeler Plc (AMFW):企業概要、財務及び戦略的SWOT分析
    Amec Foster Wheeler Plc (AMFW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Nisshin Seifun Group Inc.:企業概要・SWOT・財務分析
    Summary Canadean's "Nisshin Seifun Group Inc. : Consumer Packaged Goods - Company Profile, SWOT and Financial Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, busines …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆